Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Recent patents cover novel anticancer agents

Jan. 24, 2008

Fenofibrate shows antitumor activity via angiogenesis inhibition

Jan. 24, 2008

FDA accepts oral fludarabine NDA for review

Jan. 23, 2008

Abraxis receives E.U. approval to market Abraxane for metastatic breast cancer

Jan. 23, 2008

Synta initiates second phase I clinical trial of novel Hsp90 inhibitor STA-9090 in solid tumors

Jan. 23, 2008

FDA approves Celsion's SPA application for phase III liver cancer trial of ThermoDox

Jan. 23, 2008

Threshold provides update on several glufosfamide clinical trials

Jan. 23, 2008

Cerepro phase III trial results expected in July 2008

Jan. 22, 2008

Adherex initiates phase IIb clinical trial of ADH-1 for melanoma

Jan. 22, 2008

Endothelial progenitor cells regulate the angiogenic switch in lung metastasis model

Jan. 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...